How good enough are the new therapies for lupus nephritis? A narrative review and a position paper.

Houssiau, Frédéric
(2026) Annals of the rheumatic diseases — Vol. 85, n° 2, p. 227-234 (2026)

Files

2026_Houssiau_Ann_Rheum_Dis_AB.pdf
  • Open Access
  • Adobe PDF
  • 63.04 KB
Download
2026_Houssiau_Ann_Rheum_Dis.pdf
  • Restricted Access
  • Adobe PDF
  • 460.51 KB
Request a copy

Details

Authors
  • Houssiau, FrédéricUCLouvain
    Author
Abstract
(en) In this narrative review, the author, a privileged witness to exciting developments in the field of lupus nephritis over almost 4 decades, describes and comments on the new therapies that have recently become available, after years of trial failures. He stresses the use of combination therapy, now widely supported by expert recommendations to mitigate the risk of chronic kidney disease. He reviews the early days of cellular therapy and proposes some further lines of research.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Houssiau, F. (2026). How good enough are the new therapies for lupus nephritis? A narrative review and a position paper. Annals of the rheumatic diseases, 85(2), 227-234. https://doi.org/10.1016/j.ard.2025.10.004 (Original work published 2026)